Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry

Man-Chiu Poon, Adrienne Lee, Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Letizia Polito, Katya Moreno, Michelle Santos, Emma Iserman, Davide Matino, Alfonso Iorio

Blood (2023) 142 (Supplement 1): 1240.

https://doi.org/10.1182/blood-2023-174057

Published: 2023

Journal Articles

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger

Blood (2023) 141 (10): 1147–1158.

https://doi.org/10.1182/blood.2022016571

Published: 2023

Includes: Supplemental data

Journal Articles

Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry

Man-Chiu Poon, Adrienne Lee, Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Francis Nissen, Katya Moreno, Michelle Santos, Emma Iserman, Davide Matino, Alfonso Iorio

Blood (2022) 140 (Supplement 1): 8465–8467.

https://doi.org/10.1182/blood-2022-157531

Published: 2022

Journal Articles

Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study

Omotola O. Olasupo, Charles Nakar, Alfonso Iorio, Craig Haddix, Thushara Mathew, Lynn M Malec, Davide Matino, Lawrence Mbuagbaw, Jean-Eric Tarride, Amy D. Shapiro

Blood (2021) 138 (Supplement 1): 4990.

https://doi.org/10.1182/blood-2021-147550

Published: 2021

Journal Articles

Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry

Man-Chiu Poon, Adrienne Lee, Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Francis Nissen, Fabian Sanabria, Michelle Santos, Emma Iserman, Davide Matino, Alfonso Iorio

Blood (2021) 138 (Supplement 1): 347.

https://doi.org/10.1182/blood-2021-147195

Published: 2021

Journal Articles

Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry

Adrienne Lee, MD, Federico Germini, MD MSc, Man-Chiu Poon, MD, Arun Keepanasseril, Quazi Ibrahim, MSc, Aijing Shang, MD PhD, Francis Nissen, Oliver Meier, Cami S. Sima, MD, Davide Matino, Alfonso Iorio, MDPhD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137320

Published: 2020

Journal Articles

Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database

Olav Versloot, MSc, Emma Iserman, Pierre Chelle, PhD, Federico Germini, MD MSc, Tushara Mathew, Alfonso Iorio, MDPhD, Kathelijn Fischer

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-142816

Published: 2020

Journal Articles

Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments

Olav Versloot, MSc, Emma Iserman, Pierre Chelle, PhD, Federico Germini, MD MSc, Tushara Mathew, Alfonso Iorio, MDPhD, Kathelijn Fischer

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141801

Published: 2020

Journal Articles

Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A

Alexander Solms, Anita Shah, Sara Wiegmann, Maurice Ahsman, Erik Berntorp, Andreas Tiede, MD, Alfonso Iorio, MDPhD, Maria Elisa Mancuso, Tihomir Zhivkov, Toshko Lissitchkov

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136586

Published: 2020

Journal Articles

Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Andrea J. Darzi, Samer G. Karam, Rana Charide, Itziar Etxeandia-Ikobaltzeta, Mary Cushman, Michael K. Gould, Lawrence Mbuagbaw, Frederick A. Spencer, Alex C. Spyropoulos, Michael B. Streiff, Scott Woller, Neil A. Zakai, Federico Germini, Marta Rigoni, Arnav Agarwal, Rami Z. Morsi, Alfonso Iorio, Elie A. Akl, Holger J. Schünemann

Blood (2020) 135 (20): 1788–1810.

https://doi.org/10.1182/blood.2019003603

Published: 2020

Includes: Supplemental data

Journal Articles

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Alfonso Iorio, Monika Maas Enriquez, Heinz Delesen, Alexander Solms, Stacy E. Croteau, Erik Berntorp

Blood (2019) 134 (Supplement_1): 3637.

https://doi.org/10.1182/blood-2019-127046

Published: 2019

Journal Articles

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Blood (2019) 134 (Supplement_1): 2405.

https://doi.org/10.1182/blood-2019-127946

Published: 2019

Journal Articles

Routine Double Filtration Plasmapheresis Affects Hemostatic Proteins and Prolongs Clotting Tests

Shen Chu Xie, Anthony K.C. Chan, MBBS, FRCPC, Raimondo De Cristofaro, Alfonso Iorio, Stefano Lancellotti, Olivia Minelli, MD, Monica Sacco, Davide Matino, MD MSc

Blood (2019) 134 (Supplement_1): 1178.

https://doi.org/10.1182/blood-2019-127524

Published: 2019

Journal Articles

Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform

Pierre Chelle, PhD, Cindy Yeung, MSc, Santiago Bonanad Boix, MD, Juan Cristobal Morales, MD, Margareth C Ozelo, MD PhD, Juan E. Megias Vericat, PharmD, Alfonso Iorio, MD PhD, Jeffrey Spears, PharmD, Roser Mir, PhD, Andrea N Edginton, PhD

Blood (2018) 132 (Supplement 1): 1191.

https://doi.org/10.1182/blood-2018-99-115308

Published: 2018

Journal Articles

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Haowei Linda Sun, MD FRCPC, Ming Yang, PhD, Man-Chiu Poon, MD, Adrienne Lee, MD, Katherine Sue Robinson, MD, Michelle Sholzberg, MDM, MSc, FRCPC, John K. Wu, MBBS, FRCPC, MS, Alfonso Iorio, MD PhD, Victor S. Blanchette, FRCP, Robert J Klaassen, MD FRCPC, Shannon Jackson, MD FRCPC

Blood (2018) 132 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2018-99-113858

Published: 2018

Journal Articles

Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study

Davide Matino, MD MSc, Giancarlo Castaman, Giovanni Di Minno, Paola Giordano, MD, Maria Elisa Mancuso, Emanuela Marchesini, Flora Peyvandi, MD PhD, Elena Santagostino, Cristina Santoro, MD PhD, Michele Schiavulli, Antonella De Luca, PhD, Marco Gargaro, Paolo Puccetti, MD, Francesca Fallarino, PhD, Alfonso Iorio, MD PhD

Blood (2018) 132 (Supplement 1): 3781.

https://doi.org/10.1182/blood-2018-99-119568

Published: 2018

Journal Articles

Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study

Mark Skinner, Chatree Chai-Adisaksopha, MD, Randall Curtis, MBA, Neil Frick, Declan Noone, Brian O'Mahony, David Page, Jeffrey Stonebraker, Alfonso Iorio, MD PhD

Blood (2017) 130 (Supplement 1): 3411.

https://doi.org/10.1182/blood.V130.Suppl_1.3411.3411

Published: 2017

Journal Articles

Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a

Davide Matino, MD, Antonella De Luca, PhD, Paolo Puccetti, MD, Francesca Fallarino, PhD, Alfonso Iorio, MD PhD

Blood (2017) 130 (Supplement 1): 1070.

https://doi.org/10.1182/blood.V130.Suppl_1.1070.1070

Published: 2017

Journal Articles

Psychometric Properties of the Patient Reported Outcomes Burdens and Experiences (PROBE) Questionnaire

Chatree Chai-Adisaksopha, MD, Mark Skinner, Randall Curtis, MBA, Neil Frick, Michael B. Nichol, PhD, Declan Noone, Brian O'Mahony, David Page, Jeffrey Stonebraker, Alfonso Iorio, MD PhD

Blood (2017) 130 (Supplement 1): 5645.

https://doi.org/10.1182/blood.V130.Suppl_1.5645.5645

Published: 2017

Journal Articles

Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study

Chatree Chai-Adisaksopha, MD, Mark Skinner, Randall Curtis, MBA, Neil Frick, Michael B. Nichol, PhD, Declan Noone, Brian O'Mahony, David Page, Jeffrey Stonebraker, Alfonso Iorio, MD PhD

Blood (2017) 130 (Supplement 1): 2141.

https://doi.org/10.1182/blood.V130.Suppl_1.2141.2141

Published: 2017

NARROW

Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry

Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study

Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry

Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry

Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database

Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments

Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A

Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Routine Double Filtration Plasmapheresis Affects Hemostatic Proteins and Prolongs Clotting Tests

Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study

Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study

Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a

Psychometric Properties of the Patient Reported Outcomes Burdens and Experiences (PROBE) Questionnaire

Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only